title: Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: a meta-analysis of five randomised controlled trials.
authors.affiliation: Department of Hematology, the Affiliated DrumTower Hospital of Nanjing University Medical School, Nanjing, PR China.
authors.forename: Jing
authors.initials: J
authors.lastname: Wang
authors.forename: Ping
authors.initials: P
authors.lastname: Zhan
authors.forename: Jian
authors.initials: J
authors.lastname: Ouyang
authors.forename: Bing
authors.initials: B
authors.lastname: Chen
authors.forename: Rongfu
authors.initials: R
authors.lastname: Zhou
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D016017:Odds Ratio; D011292:Premedication; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction / Q000379:methods; D018401:Sample Size
chemical_list: D016179:Granulocyte Colony-Stimulating Factor